UL16-binding protein family ligand (ULBP (for the family); individual members include ULBP1, ULBP2, ULBP3, etc.)

The UL16-binding protein family ligands are a group of cell surface glycoproteins structurally related to MHC class I molecules but lacking the α3 domain and transmembrane segment. Instead, they are anchored to the membrane via a GPI anchor. These proteins—including several members such as ULBP1, ULBP2, ULBP3, and others—are induced by cellular stress such as viral infection or transformation. Their primary biological role is serving as ligands for the activating immunoreceptor NKG2D found on natural killer (NK) cells and subsets of T-cells. Engagement of NKG2D by these ligands triggers NK cell-mediated cytotoxicity against stressed, infected, or malignant cells and stimulates production of various cytokines including IFN-gamma. The name "UL16-binding protein" derives from their ability to bind the human cytomegalovirus glycoprotein UL16—a mechanism used by HCMV to evade immune detection by retaining these proteins intracellularly rather than allowing them to reach the cell surface where they would activate NK cells. The interaction between ULBPs/MICs with NKG2D is central in innate immunity against tumors and infections. There are no approved drugs that directly target this ligand family yet; however, their role in modulating immune responses makes them an area of active research for cancer immunotherapy and antiviral strategies. Overactivation risks include potential autoimmunity due to excessive stimulation of NK/T-cell activity.[2][3][4][5]

Other names

UL16-binding proteinULBPsRetinoic acid early transcript 1 (RAET1) familyNKG2D ligand (family context)MICB and MICA are related but distinct ligands also bound by UL16[2][3][7]

biologically, they activate NKG2D receptor on NK/T-cells to trigger cytotoxicity and cytokine release